Rescriptor (delavirdine) was one of the first HIV antiretroviral (ARV) medications approved by the FDA. It hasn't been a first choice treatment option for many years, and is no longer available in the United States.
Rescriptor (delavirdine) is a HIV ART (antiretroviral therapy) medication that stops the HIV virus from infecting your cells. It's in a subclass called "NNRTI," similar to HIV ARTs like Sustiva or Edurant, which are more commonly used.
No, there are no brand or generic versions available in the U.S.
The FDA reported that the manufacturer decided to stop making Rescriptor (delavirdine) for business reasons, not safety. It could be that the demand for the medication was too low after newer HIV ARTs became available.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.